About the Company
Our purpose at Talis is to advance health equity and outcomes by delivering accurate infectious disease testing in the moment of need, at the point of care.
While timely diagnosis of infectious diseases is critically important to enable effective treatment, testing is primarily performed in centralized laboratories, which require samples to be shipped for processing, delaying the return of results by days. Point-of-care testing solves this problem by delivering the timely information necessary for clinical care.
To deliver our purpose we focus on three things:
As a valued member of our engineering team, you will join a group of highly engaged, focused, and collaborative engineers to manage hardware delivery timelines. We are looking for a generalist that is knowledgeable in a variety of biomedical engineering topics, but who is more importantly not afraid to roll up their sleeves, learn new things, and take on new challenges.
Specific responsibilities include, but are not limited to:
Education/Skills/Requirements
Job Location: Chicago
Remote Work Option: Occasional, pre-dominantly in-office
Expected Travel: 35%
Talis offers a comprehensive health and well-being benefits programs, long-term equity incentives, time-off policies, a 401(k) retirement savings plan with an immediate Company match, Education Assistance Program, a rotating suite of snacks, Monday breakfasts, Happy Hours, other fun company events and more! Best of all, join us by working at a growing company like Talis with dedicated and collaborative employees committed to making a difference in Health Care.
Talis is proud to be an equal opportunity workplace. All aspects of employment decisions will be based on merit, competence, performance, and business needs. We do not discriminate on the basis of any status protected under federal, state, or local law. We celebrate diversity and are committed to creating an inclusive environment for our colleagues.
More About Talis:
Built on a foundation of world-class science and engineering, we are developing the Talis One platform, a sample-to-answer, cloud-enabled molecular diagnostic platform that could be rapidly deployed to distributed diagnostic settings in the United States and around the world to diagnose infectious disease at the point-of-care. The Talis One platform comprises a compact instrument, single-use test cartridge, and innovative software including a central cloud database. This system is designed to provide central laboratory levels of accuracy and be operated by an untrained user.
Talis has raised more than $500 million to date and went public in February 2021.